Johnson & Johnson (JNJ) said Thursday that the European Commission has granted a Conditional Marketing Authorization for its single-dose COVID-19 vaccine.
The authorization comes hours after receiving a positive opinion from the European Medicines Agency's the Committee for Medicinal Products for Human Use or CHMP for the vaccine.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com